His main research concerns Internal medicine, Gastroenterology, Cirrhosis, Surgery and Hepatocellular carcinoma. His Endocrinology research extends to Internal medicine, which is thematically connected. His work in the fields of Hepatology overlaps with other areas such as Placebo-controlled study.
His Cirrhosis study combines topics in areas such as Liver disease and Decompensation. His biological study spans a wide range of topics, including Multivariate analysis and Hazard ratio. His research in Hepatocellular carcinoma intersects with topics in Cancer, Liver function, Oncology and Pathology.
Markus Peck-Radosavljevic spends much of his time researching Internal medicine, Gastroenterology, Hepatocellular carcinoma, Cirrhosis and Portal hypertension. His Internal medicine research incorporates elements of Surgery and Oncology. Markus Peck-Radosavljevic has included themes like Hepatitis C, Immunology, Ribavirin and Liver transplantation in his Gastroenterology study.
His research integrates issues of Liver function and Carcinoma, Pathology in his study of Hepatocellular carcinoma. His Cirrhosis research is multidisciplinary, incorporating perspectives in Endocrinology and Radiology. He does research in Portal hypertension, focusing on Transjugular intrahepatic portosystemic shunt specifically.
His primary scientific interests are in Internal medicine, Gastroenterology, Hepatocellular carcinoma, Portal hypertension and Cirrhosis. As part of his studies on Internal medicine, he often connects relevant areas like Oncology. His study in Gastroenterology is interdisciplinary in nature, drawing from both Ribavirin, Sofosbuvir, Liver transplantation and Hepatitis C.
His Hepatocellular carcinoma study combines topics from a wide range of disciplines, such as Cancer, Liver function, Carcinoma and Phases of clinical research. His work deals with themes such as Endocrinology, Virologic response, Transient elastography, Radiology and Hepatic decompensation, which intersect with Portal hypertension. The Cirrhosis study combines topics in areas such as Decompensation, Univariate analysis and Ascites.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The burden of liver disease in Europe. A review of available epidemiological data.
Martin Blachier;Henri Leleu;Markus Peck-Radosavljevic;Dominique Charles Valla.
Journal of Hepatology (2013)
Effect of everolimus on survival in advanced hepatocellular carcinoma after failure of sorafenib: the EVOLVE-1 randomized clinical trial.
Andrew X. Zhu;Masatoshi Kudo;Eric Assenat;Stéphane Cattan.
Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial
Michael Manns;Didier Samuel;Edward J Gane;David Mutimer.
Lancet Infectious Diseases (2016)
Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis.
Simona Bota;Harald Herkner;Ioan Sporea;Petra Salzl.
Liver International (2013)
Hepatocyte IKKβ/NF-κB Inhibits Tumor Promotion and Progression by Preventing Oxidative Stress-Driven STAT3 Activation
Guobin He;Guann Yi Yu;Vladislav Temkin;Hisanobu Ogata.
Cancer Cell (2010)
Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt
B Angermayr;M Cejna;F Karnel;M Gschwantler.
Nonselective β blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis.
Mattias Mandorfer;Simona Bota;Philipp Schwabl;Theresa Bucsics.
An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis.
Angelo Luca;Angelo Luca;Berhard Angermayr;Guido Bertolini;Franz Koenig.
Liver Transplantation (2007)
Platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: results of a multicenter, prospective, validation study.
Edoardo G Giannini;Atif Zaman;Anna Kreil;Annarosa Floreani.
The American Journal of Gastroenterology (2006)
The ART of decision making: Retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma
Wolfgang Sieghart;Florian Hucke;Matthias Pinter;Ivo Graziadei.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: